BSL-4: AUTHORIZED PERSONNEL ONLY NATIONAL CENTRE FOR CASE STUDY TEACHING IN SCIENCE by NICOLE MARIE ANTHONY Biological Sciences Teacher Toronto District.

Slides:



Advertisements
Similar presentations
Laboratory Biosafety Pathogenic Microbiology and Virology Laboratories.
Advertisements

Scientific Name: Ebola Virus
* Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. * EBOLA is a rare but deadly virus.
What is Ebola? 10/12/2014. What is Ebola? Filoviridae Ebolavirus – 5 viruses/species – Ebola (Zaire) – Sudan – Bundibugyo – Tai Forest – Reston Marburgvirus.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
What is Ebola? Ebola is a rare and deadly disease caused by infection with the Ebola virus. It is only spread by direct contact with an infected person's.
Ebola – Facts, Myths, and Fiction Dr M. Oladoyin Odubanjo Executive Secretary, The Nigerian Academy of Science (NAS) 1st Vice Chair, Association of Public.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
Ebola Virus. What is Ebola hemorrhagic fever? Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys,
Highly containment laboratory in the National Institute of Infectious Diseases, Tokyo, Japan: activities, circumstances, and future challenges Masayuki.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
The current outbreak of Ebola in west Africa is both a public health emergency of international concern and a human tragedy.
Crimean-Congo Hemorrhagic Fever. Overview Organism History Epidemiology Transmission Disease in Humans Disease in Animals Prevention and Control Center.
Discovering the World of Viral Hemorrhagic Fevers By Christy Leaman.
©2014 MFMER | slide-1 GMCH, Louisville November 2014 Ebola!
An Introduction to Biological Safety Dr. A. Mantalaris Biological Safety Officer (ACE 515, Tel: x45601)
2014 Ebola Virus Outbreak. What is a Virus? Viruses are microscopic particles (10 – 400 nm). Viruses are made of genetic material (DNA or RNA) surrounded.
Ebola Hemorrhagic Fever Anderson Coates Michael Mastropole.
Marburgviruses and Ebolaviruses – History, Fiction, and the Facts MIT Faculty Dinner Series on Biosecurity September 29, 2005 Jens H. Kuhn.
Ebola Hemorrhagic Fever. Viral Overview
Ebola Virus Outbreak This presentation has been prepared by Christine H. Herrmann, Ph.D. of the Department of Molecular Virology and Microbiology at Baylor.
Ebola virus  The Ebola virus causes an acute, serious illness which is often fatal if untreated.  The most severely affected countries are: Guinea,
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Ebola virus disease. Key facts Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The.
EBOLA - ZAIRE. PPE – Personal Protection Equiptment.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Reston in the Philippines Catalino S. Demetria, DVM.
Rationale Ebola is a virus that greatly effects not only the human population in various parts of the world, but also in animals such as chimpanzees and.
EBOLA VIRUS FREQUENTLY ASKED QUESTIONS. What is Ebola virus disease? (Formerly Ebola haemorrhagic fever)- a severe, often fatal illness, with a DEATH.
Ebola Virus Disease Clinical manifestations Ebola Virus Disease Clinical manifestations N. Shindo Lead, Clinical & Infection Control Pandemic & Epidemic.
Safety. Four Simple Questions What are the hazards? What are the hazards? What are the worst things that could happen? What are the worst things that.
Introduction 1) Viruses 2) Interspecies Transmission processes 3) Biodiversity Damage Conclusion / Opening.
Discuss the major characteristics of the four Biosafety Levels. Define “Risk Group” and give an example of each. Discuss how Risk Groups are used in conjunction.
By: Miguel Lopez.  The Zaire Ebola Virus (commonly known as Ebola) is the cause of the disease Ebola hemorrhagic fever (EHF) which cause unstoppable.
Health Security and Emergencies Ebola Response 13 October 2014.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
EBOLA HAEMORRHAGIC FEVER – BLEEDING FEVER 7NEWS EBOLA UPDATE.
Training on the Ebola Virus Disease (duration 3 days)
11 11/16/2015 Filo Viruses Hugh B. Fackrell Filename: Filovir.ppt.
Bioscience Safety Unit PROPERTY OF PIMA COUNTY JTED,
By: Laila El-Ali & Anna Moore.  Ebola is short for Ebola Hemorrhagic Fever  Virus  The virus has been known since the year of 1976 in Zaire  A person.
Rationale Marburg Hemorrhagic Fever is a highly fatal disease and it is less known than Ebola. Together, Ebola and Marburg make up the Filoviridae family.
Emerging Diseases Lecture 9: Filoviruses 9.1 Overview 9.2: Outbreaks: Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa 9.3 Summary.
Viral Hemorrhagic Fevers - Filoviridae
Outbreaks and Epidemics Ebola Hemorrhagic Fever. Ebola facts and origins  Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman.
Ebola Virus Disease (EVD) Presented by Joe Willett, Jenny Nguyen,
South River Machar Fire Department Ebola Virus Disease.
John J. Lanza, MD, PhD, MPH, FAAP Florida Department of Health A Public and Clinical Health Perspective.
Filoviruses. Filoviruses (Filoviridae) Marburg and Ebola viruses filamentous, enveloped, negative-strand RNA viruses. These agents cause severe or fatal.
Ebola Virus Sadie Fuson, Gina Cackovic, and Abby Steer.
Submitted by: Susan Henry Keith Noble
Ebola. Discovery 1976 near Ebola River Valley in Africa.
Ebola Virus Disease: Occupational Safety and Health.
Ebola Virus BY: HEATHER BRANDSTETTER SAMANTHA LACLAIR JENNA HENSEL DANIELLE GILFUS.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
Information on the Ebola surge in West Africa All you need to know about Ebola (HF) -Jazlyn Selvasingh.
Patient with Ebola Hemorrhagic Fever, Bumba Zone, Equateur Province, DR Congo (Zaire), October 1976.
The Hot Zone By Richard Preston
DR I.O.LAWAL MBChB(Ife),FWACS(Urol). EBOLA VIRUS DISEASE Introduction Epidemiology Transmission Signs & Symptoms Diagnosis Differentials Treatment/ Health.
Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa
Working with Biological Hazards
Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa
Copyright © 2018 American Academy of Pediatrics.
Ebola Hemorrhagic Fever
Active Surveillance for EHF Cases, Equateur Province, DR Congo (Zaire), November-December 1976
Marburg, N’zara, Yambuku, Reston, Kikwit, West Africa
EBOLA VIRUS INFORMATION
Ebola Facts October 15, 2014.
Learning Outcomes • Ebolavirus • Classification
Presentation transcript:

BSL-4: AUTHORIZED PERSONNEL ONLY NATIONAL CENTRE FOR CASE STUDY TEACHING IN SCIENCE by NICOLE MARIE ANTHONY Biological Sciences Teacher Toronto District School Board 1

Group Brainstorming Based on the information presented in the case so far, address the following questions in your groups: 1.What problem is presented? 2.What do we know about the problem? 3.What is still unknown about the problem? 2

CQ#1: What does “BSL-4” stand for? A.Bachelor of Science in Law (4-year degree) B.Biological Space Laboratories (Unit 4) C.Biosafety Level (Category 4) D.Breed-specific legislation (Section 4) 3

CQ#2: BSL-4 category agents are: A. not associated with disease in healthy humans. B.associated with human disease that is rarely serious and for which preventative or therapeutic interventions are often available. C.associated with serious or lethal disease for which preventative or therapeutic interventions may be available. D.associated with serious or lethal human disease for which preventative or therapeutic interventions are not usually available. 4

CQ#3: Which type of pathological agent(s) is/are classified under the BSL-4 category? A.Viral agents B.Fungal agents C.Bacterial agents D.Parasitic agents E.All of the above 5

CQ#4: Based on the information revealed in the story so far, what type of pathogenic agent do you think Claire and Dr. Preston have contracted? A.Viral agent B.Fungal agent C.Bacterial agent D.Parasitic agent E.Difficult to determine with the given information 6

CQ#5: Based on the information revealed in the story so far, do you think Claire and Dr. Preston will survive? A.Yes B.No C.Difficult to determine with the given information 7

Disease Detective Rewind back to December of 2013; the time of the onset of the outbreak in West Africa. Imagine that you are a medical health official and that a cluster of illnesses have appeared at your clinic, all of which present with similar symptoms. Many of the cases have been fatal and you need to make a diagnosis immediately in order to stop the spread and to properly treat the sick patients. Consider these questions and discuss them within your group. 1.What steps would you take to make a diagnosis? 2.What are some ways to determine which pathogen is responsible for the outbreak? 3.What measures would you employ to prevent further spread of the disease? 8

CQ#6: Do all three of the pathogens that you selected appear in the list below? A.Yes B.No Lassa Fever Ebola Hemorrhagic Fever Malaria Marburg Hemorrhagic Fever Crimean-Congo Hemorrhagic Fever Typhoid Fever 9

CQ#7: Which grouping consists of the three best matched pathogens to this case? A.LF, Malaria, TF B.MHF, Malaria, TF C.CCHF, MHF, EHF D.TF, EHF, MHF E.EHF, Malaria, MHF F.LF, TF, CCHF G.TF, MHF, CCHF 10

Recognizing the Biosafety Levels After completing the Quick Learn Lesson, you should be able to correctly identify BSLs. Select the biosafety level described by the conditions in the following examples. 11

CQ#8: A microbiology graduate student is working on a project under the following conditions: Work is conducted on a standard laboratory table or bench. A nonpathogenic laboratory strain of E. coli is being used. Minimal PPE, such as a lab coat, gloves, and eye protection might be worn but are not necessary. A.BSL - 1C. BSL - 3 B.BSL - 2D. BSL

CQ#9: Select the biosafety level shown in the photo. A.BSL - 1C. BSL - 3 B.BSL - 2D. BSL

CQ#10: Select the biosafety level described by the conditions of the following example. Levels are listed below. Work is conducted on a standard laboratory bench in a contained area. PPE, including a lab coat, gloves, and eye protection are being used to reduce accidental infection. A.BSL - 1C. BSL - 3 B.BSL - 2D. BSL

CQ#11: Select the biosafety level shown in the photo. A.BSL - 1C. BSL - 3 B.BSL - 2D. BSL

CQ#12: Which ELISA format is the most suitable for this case? (Lab Activity A, Question 1) A.Direct B.Indirect C.Sandwich D.Competition/Inhibition 16

CQ#13: Based on the test results from patient zero’s sample, which virus caused the outbreak? (Lab Activity A, Question 2) A.Ebola hemorrhagic fever virus B.Marburg hemorrhagic fever virus C.Crimean-Congo hemorrhagic fever virus D.Test results are inconclusive 17

A sign warns visitors that area is a Ebola infected. MAKOUA CONGO AFRICA - SEPTEMBER

CQ#14: Based on the phylogenetic tree, which strain is the virus isolated from patient zero’s sample most closely and least closely related to? (Lab Activity B, Question 1) A.Zaire; Sudan (respectively) B.Zaire; Bundilbugyo (respectively) C.Bundilbugyo; Zaire (respectively) D.Sudan; Reston (respectively) E.Zaire; Cote d’Ivoire (respectively) F.Results from the tree are inconclusive 19

Supplemental Material 20

1. Average Fatality Rate by Ebola Virus Strain 2. How Ebola is Transmitted 3. Fruit Bat Territory Overlay of Outbreaks 4. Ebola Virus Structure and Genome Organization 5. Filovirus Replication in a Cell 6. Ebola Virus Phylogeny, including Guinea Strains 7. Zaire Ebola Virus Phylogeny 8. Haemorrhagic Manifestations in Monkeys guinea-2014-ebov-ebolavirus-outbreak-2/ 21

Yambuku, Ebola Virus Discovery Team 22

Slide 1 & 18 Description: Attention Ebola. Makoua Congo Africa – September : A sign warms visitors that area is Ebola infected. Source: ©SURZ- Stock Photo ID: Clearance: License to be purchased by the author of this case pending NCCSTS approval. Slides 13 and 15 Description: Biosafety equipment and practices. Source: CDC, Recognizing the Biosafety Levels Clearance: Images are in the public domain. Slide 22 Description: Photo of Peter Piot, circa Source: American Association for the Advancement of Science. Accessed from: first-encounter-ebola first-encounter-ebola Clearance: Permission for use has not been obtained. 23 Image Credits